720 related articles for article (PubMed ID: 17143041)
1. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
Chauhan VS; Selvaraj RJ
Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
3. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
5. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
6. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
Chow T; Joshi D
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
[TBL] [Abstract][Full Text] [Related]
7. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
9. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.
Haghjoo M; Arya A; Sadr-Ameli MA
Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329
[TBL] [Abstract][Full Text] [Related]
10. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
11. [The microvolt T-wave alternans test].
Görmez S; Erciyes D; Gülbaran M
Turk Kardiyol Dern Ars; 2010 Sep; 38(6):436-43. PubMed ID: 21200127
[TBL] [Abstract][Full Text] [Related]
12. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
[TBL] [Abstract][Full Text] [Related]
13. [Risk stratification for sudden cardiac death: from the electrophysiological study to T-wave alternans].
Pedretti RF; Sarzi Braga S; Vaninetti R; Laporta A; Masnaghetti S; Raimondo R; Rubin D; Santoro F; Salerno M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):33S-39S. PubMed ID: 19195304
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic evaluation of cardiovascular status.
Wung SF; Kozik T
J Cardiovasc Nurs; 2008; 23(2):169-74. PubMed ID: 18382260
[TBL] [Abstract][Full Text] [Related]
15. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
Armoundas AA; Hohnloser SH; Ikeda T; Cohen RJ
Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):522-8. PubMed ID: 16186850
[TBL] [Abstract][Full Text] [Related]
16. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
[TBL] [Abstract][Full Text] [Related]
17. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator.
Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R
Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296
[TBL] [Abstract][Full Text] [Related]
18. T-wave alternans and sudden cardiac death.
El-Menyar A; Asaad N
Crit Pathw Cardiol; 2008 Mar; 7(1):21-8. PubMed ID: 18458663
[TBL] [Abstract][Full Text] [Related]
19. Sudden death prophylaxis in heart failure.
Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
